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In the past decade the mechanistic evaluation of the structural basis
for the function of the neurotransmitter:sodium symporters (NSS) pro-
teins has been enriched greatly by the availability of crystallographicallyotein interactions.
and Biophysics, Weill Cornell
, room LC-501A, New York, NY
6.
vili).determinedmolecularmodels, startingwith very ﬁrst X-ray structure of
Leucine transporter (LeuT) [1], the bacterial homolog of the neurotrans-
mitter transporters [2] that rapidly became a prototype for extensive
structure-function studies. The initial structure of LeuT revealed a trans-
membrane (TM) bundle composed of 12 helical segments that incorpo-
rated a centrally located primary substrate binding site (S1) and two
Na+binding sites, Na1 andNa2. These siteswere occluded fromboth in-
tracellular (IC) and extracellular (EC) vestibules exposed to the aqueous
environment. Subsequent crystallographic studies [3–9] captured LeuT
and its mutant constructs (mostly dictated by crystallization require-
ments, or an engineered Cl− site [10]), in various other conformations
Fig. 1. Sequences of the N-terminal regions of the human dopamine transporter (hDAT),
serotonin transporter (hSERT), norepinephrine transporter (hNET), and vesicular mono-
amine transporter 2 (hVMAT2); positively charged Arg/Lys residues are indicated in red,
Ser/Thr residues that are potentially targeted for phosphorylation, are in green.
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ligands in the S1 site, as well as with tricyclic antidepressants in the
EC vestibule. A variety of yet additional states that can be accessible to
the proteins that share LeuT-like architecture, were inferred from
forms of LeuT in the presence and absence of ligands and ions [11],
and crystallographic models of other bacterial transporters with similar
architecture (the “LeuT fold”) [12–21].
The availability of such a rich repertoire of structures has prompted
various formulations of mechanistic models of the transport cycle in
NSS proteins directly from structure [22–25], consistent with the alter-
nating accessmechanism [23]. Not surprisingly, however, experimental
and computational studies of the dynamic properties of the LeuT proto-
type under various conditions showed that these direct approximations
from structure were incomplete (see, for example, Refs. [26–28]).
Indeed, ensemble and single-molecule level spectroscopic measure-
ments on LeuT [28–31] and onMhp1 [26], aswell as enlightening atom-
istic scale computational simulations of LeuT [9,27–39] and of homology
models of mammalian dopamine (DAT) [40–44] and serotonin (SERT)
[45,46] NSS transporters, provided valuable mechanistic insights into
ion- and ligand-dependent conformational dynamics in NSS proteins.
Together, these ﬁndings suggest that the alternating access is
achieved through concerted dynamic rearrangements in speciﬁc
structural motifs of the protein [47]. Indeed, extensive computation-
al modeling and simulations of the system [27,32–38] focused on the
detailed manner in which binding of substrate and ions from the
extracellular side of the transporter induces conformational changes
in the protein leading to the translocation of substrate and ions
towards the intracellular vestibule. Furthermore, ligand binding
and uptake measurements in LeuT together with computational
modeling [32,48,49] have suggested a mechanistic model of allos-
teric Na+-coupled symport in which intracellular release of the S1-
bound substrate is triggered by the binding of a second substrate
molecule in the extracellular vestibule located ~11 Å above the S1
site, termed the S2 site.
Recently, the very ﬁrst X-ray structure of eukaryotic NSS protein,
DAT from Drosophila melanogaster (dDAT) in complex with tricyclic an-
tidepressant nortriptyline, has been reported [50]. In this structure,
dDAT is in outward-open state, similar to LeuT model stabilized by an
inhibitor tryptophan [4], providing novel insights into relationships
between the bacterial prototype LeuT, and the eukaryotic neurotrans-
mitter transporters.
Members of the NSS family, in addition to DAT and SERT, include the
transporters of the neurotransmitters γ-aminobutyric acid, glycine, and
norepinephrine (respectively known as GAT, GlyT, and NET), which are
responsible for the clearance of the neurotransmitters from the synaptic
cleft and their translocation back into the presynaptic nerve terminal
[51–56]. In the function of these NSS, neurotransmitter reuptake into
the presynaptic cell is powered by coupling to the transmembrane sodi-
um gradients. Their functions in neuronal signaling have made these
transporters primary targets for medications [57], and they have been
implicated in the mechanisms of action of abused psychostimulants,
such as cocaine and amphetamine (AMPH), and in various psychiatric
and neurological disorders that include drug addiction, schizophrenia,
and Parkinson's disease [58].
Interestingly, while there have been several reports regarding a role
for the membrane in which the NSS are embedded, in their functional
mechanisms (e.g., see [59–61]), until recently there had been no exper-
imental evidence to suggest a role for plasma membrane components
in speciﬁc modes of regulation of the NSS proteins. This was changed
by in vitro and in vivo studies on DAT [62] and SERT [63] that
have unambiguously established a direct involvement of PIP2
(phosphatidylinositol 4,5-biphosphate) lipids in the transport mecha-
nisms of these NSS proteins.
PIP2 lipids are strongly anionic (with a net charge of −4e at
neutral pH) and represent only a minor fraction of the phospholipid
composition of the cytoplasmic leaﬂet of plasma membranes [64,65].Nevertheless, they regulate many cellular processes by affecting func-
tion and organization of both peripheral and integral membrane pro-
teins. For example, PIP2 lipids anchor various proteins to the cell
membrane through interactions with speciﬁc sensor domains, such as
the pleckstrin homology (PH)domain [66] and have been shown to reg-
ulate the function of various channels and enzymes (reviewed in Ref.
[67]). The evidence implicating PIP2 lipids, for the ﬁrst time, in the
function of the NSS is thus much more recent [62,63].
Here we review the recent ﬁndings regarding NSS/PIP2 lipid interac-
tions and discuss their signiﬁcance to the physiology of the NSS trans-
porters. The evaluation of the mechanisms at the molecular-level that
has emerged from combined experimental and computational studies
of the phenotypes, is shown to produce novel mechanistic insights re-
garding the role of the long N- and C-terminal regions of the mammali-
an NSS members in functional mechanisms regulated by PIP2 lipids. As
the mechanisms of regulation involve direct association of these termi-
nal domainswith PIP2 lipids, we provide a structural context, from com-
putational modeling, for the dynamics of the interactions between PIP2
lipids and the N-terminus of the NSS proteins and themanner in which
functional properties of speciﬁc physiological actions of the NSS are
affected.2. Terminal loops as functional units of
neurotransmitter transporters
While the crystallographic data shows that the TM bundle of LeuT
and dDAT share remarkable similarity, as would be expected for closely
related members of the LeuT-fold protein family [1], one of the major
structural differences between the bacterial transporters and the neuro-
transmitter transporters (NT-s) is thepresence inNTproteins of long in-
tracellular N-terminal (N-term) and C-terminal (C-term) segments.
This difference is expected to be of signiﬁcant mechanistic importance
as intracellular loop regions of membrane proteins are often identiﬁed
as functional domains. For example, as substrates for kinases in EGFR,
and connections to the signalosome of GPCRs (e.g., see [68,69]). In the
structures of the NT-s, theN-term and C-term segments contain numer-
ous putative phosphorylation sites (Fig. 1), and various protein kinases
have been implicated in the regulation of the function of the transporter
proteins on this basis [70–73]. For DAT, speciﬁcally, the phosphorylation
of the Ser residues distal (farthest from the TM bundle) in the
N-terminal segment (Fig. 1) has been shown to be carried out
by Ca2+/calmodulin-dependent protein kinase II (CaMKII) and to
require binding of CaMKII to the C-term of the DAT [74]. Notably, this
phosphorylation is involved in the interesting phenotype of
amphetamine-dependent efﬂux whereby the substrate, e.g., DA, is
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the cell [71,75–78]. The process of efﬂux initiated under physiological
conditions by the action of psychostimulants like AMPH, was shown
to require the presence of various juxtamembrane proteins such as
the lipid raft protein Flotillin-1 [79,80], as well as association of the
DATN-termwith the SNARE protein Syntaxin-1A (STX) [81]. Functional
interactions of STX with N-terminal regions of other NSS proteins, such
as SERT, NET, and GAT have also been reported [82–86].
Importantly, the AMPH-induced efﬂux is measurable also for these
other NT proteins, and in all cases reported thus far the efﬂux process
has been linked to the phosphorylation of the N-term of the NT-s. For
example, in SERT [87], AMPH-induced serotonin (5-HT) efﬂux has
been suggested to be related to phosphorylation of the highly conserved
T81 residue in the N-term (residue numbering according to human
SERT, hSERT, see Fig. 1) by protein kinase C (PKC). Interestingly,
phosphorylation of the residue analogous to hSERT T81 in the N-term
of DAT (i.e., S53 in humanDAT, hDAT, see Fig. 1), has also been implicat-
ed in AMPH-induced DA efﬂux [88]. Furthermore, efﬂux of 5-HT
through the vesicular monoamine transporter 2 (VMAT2) [89],
triggered by methamphetamine (METH), has been linked to phosphor-
ylation of Ser residues in the 16-SRRSRK-20 stretch of the VMAT2
N-term (Fig. 1).
The structure–function relationship between N-term phosphoryla-
tion and efﬂux has been investigated in various NT-s through deletions
of speciﬁc motifs or by substitutions of speciﬁc Ser or Thr residues
(i)-with Asp (S/D, T/D), to mimic phosphorylation, or (ii)-with Ala
(S/A, T/A), to interfere with phosphorylation (Fig. 1). Thus, expression
in cells of hDAT constructs with either simultaneous S/A mutations in
all ﬁve Ser residues in the distal N-term (Fig. 1), or with the ﬁrst 22
residues truncated, led to resistance to AMPH-induced efﬂux [75].
AMPH-induced efﬂux was restored by S/D mutations in the same ﬁve
positions. Remarkably, none of the above structural modiﬁcations
affected DA uptake by hDAT. These results demonstrated, that substrate
transport in the inward and reverse directions could be independently
regulated in this NT, raising the possibility of interfering selectively
with AMPH-induced DA efﬂux without altering physiological DA
uptake. In this respect, it is important to note the recent discovery of
several speciﬁc de novo mutations in hDAT that are linked to various
neurological disorders and affect the efﬂux phenotype in particular
[90–97].
Interestingly, when constructs of rat DAT with mutations of T53
(S53 in hDAT) to either alanine or aspartate (T53A or T53D) were
reconstituted in cells, the detected levels of AMPH-induced efﬂux
were negligible [88], similar to the hSERT constructs in which T81
(analogous to T53 in rat DAT) was substituted with either Ala or Asp
and did not produce reverse transport when expressed in cells [87].
Importantly, however, these mutants showed as well decreased levels
of normal uptake for both DAT and SERT constructs. Similarly, in
VMAT2 [89], simultaneous mutations of N-terminal Ser15 and Ser18
residues to either Ala or Asp (Fig. 1) not only substantially reduced
substrate efﬂux but also lowered normal substrate uptake. Puzzlingly,
this is in contrast to the phenotypes identiﬁed for S/D and S/A mutants
in the distal N-term part of the hDAT (i.e., closest to the N-terminal end
of the protein) [75]. Indeed, as described above, simultaneous S/A sub-
stitutions in Serines at positions 2, 4, 7, 12, and 13 (see Fig. 1) could
not sustain AMPH-induced efﬂux, whereas S/D mutations in the same
residues resulted in efﬂux-competent transporters. Furthermore,
neither S/D or S/A substitutions in the distal N-term affected normal
substrate uptake.
Together, these experimental studies have established that
N-terminal regions of NT proteins actively participate in the functional
mechanisms via phosphorylation. But they also have revealed more
multifaceted role of the N-term segment in function of NT-s. This has
been perhaps demonstrated best in hDAT, as detailed above, by the
experimental results suggesting that while the distal 22 N-terminal
residues selectively control the efﬂux process, the proximal end of theN-term that is adjacent to the hDAT TM bundle, appears to regulate
both inward and reverse transport of the substrate.
3. Functional interactions of SERT and DAT with PIP2 components of
the membrane
The recent demonstrations that the efﬂux process in DAT [62] and
SERT [63] depends on the availability of plasma membrane PIP2 lipid,
point to a novel and important cofactor in the surrounding membrane,
which can selectively regulate efﬂux mechanisms in NSS proteins. The
ﬁrst illustration that PIP2 component plays an important role in
functional mechanisms in NSS proteins comes from the studies on
SERT. Thus, the actions of AMPH at SERT were shown to require PIP2
lipids in the plasma membrane [63] when hSERT-mediated efﬂux
and currents were compared in control cells and in cells treated with
either PIP2-sequestering peptide (e.g., the PIP2 binding domain of the
Kv7.2 channel) or phospholipase C (PLC) activator agent to deplete
PIP2 levels in the membrane. Sequestering or depleting PIP2 reduced
SERT-mediated 5-HT efﬂux induced by an AMPH derivative (pCA;
para-chloramphetamine) while leaving physiological 5-HT uptake
unchanged.
Evaluation of electrostatic properties of IC loop regions in hSERT
suggested several sites on the transporter that could potentially be
involved, directly or indirectly, in interactions with PIP2 lipids. Speciﬁ-
cally, three basic residues, R144 (in ICL1), K352 (in ICL3), and K460
(in ICL4) were identiﬁed and mutated to Ala separately or in combina-
tion in order to test their functional importance. While the hSERT
constructs bearing the single pointmutations did not alter the function-
ality of the transporter (i.e. both uptake and reverse transport of the
substrate were unchanged), the R144A/K352A, R144A/K460A, and
K352A/K460A double mutants of hSERT had lower pCA-induced efﬂux
levels than those measured in cells expressing the wild type hSERT.
Efﬂux in these double mutant constructs was not completely abolished,
however, and PIP2 lipid depletion performed in the background of these
mutations affected pCA-induced efﬂux only for R144A/K352A and
R144A/K460A hSERT but not for the K352A/K460A variant which nei-
ther bound PIP2 nor mediated pCA-evoked currents. In contrast,
R144A/K352A and R144A/K460A mutants showed pCA-induced
currents that were comparable to those through the wild type hSERT.
While these studies have established the requirement for PIP2 lipids
in psychostimulant actions at SERT, it remained unclear (1)—whether
PIP2 lipids regulate efﬂux in SERT, or indeed in NSS proteins in general,
through direct interactions with the transporter; and, if they do,
(2)—what mode of PIP2 binding underlies the functional mechanisms.
This became clearer frommore recent studies onDAT [62]which unam-
biguously demonstrated direct interactions of PIP2with this NSS. Specif-
ically, co-localization of hDAT with PIP2 lipid sensor (PH domain from
PLC) was detected using live confocal imaging on cells transfected
with hDAT. Furthermore, the association of PIP2 lipids with DATwas re-
vealed by immunoprecipitation assays performed in striatal tissues of
mice, demonstrating that PIP2 associates with DAT both in cell cultures
as well as ex vivo. In addition, direct interaction between PIP2 and the
N-term of DAT in vitro was shown in lipid binding assays by using
GST-fused hDAT N-term construct containing ﬁrst 64 N-terminal
amino acids. That the association between hDAT N-term and PIP2 lipids
is driven by electrostatic forces is suggested from additional lipid bind-
ing experiments performed on hDAT N-term constructs with either
K3A/K5A or K3N/K5N double mutations (Fig. 1). These charge-
neutralizing substitutions signiﬁcantly inhibited the ability of hDAT
N-term to bind PIP2 lipids [62].
The functional consequences of the association between the hDAT
N-term and PIP2 lipids were probed in assays of substrate uptake and
efﬂux. The PIP2 content of the membranes was manipulated either by
depleting cellular stores of PIP2 lipids (through activation of the PLC
enzyme that stimulates PIP2 hydrolysis), or with PIP2-sequestering pep-
tides (see above). As in SERT, both PIP2 depletion and sequestration
Fig. 2. Electrostatic potential isosurfaces (EPIs) (+1kt/e values shown as blue wireframes
and −1kt/e as red wireframes) derived from the predicted structures for: (A) human
VMAT2 (hVMAT2, residues 1–20); (B) hDAT N-terminus (residues 1–59). In both panels,
the locations of basic residues and Serine residues are indicated by labels and black arrows,
and highlighted in yellow and white space-ﬁll representations, respectively. Note the ex-
tended EPI in the hDATN-term, generated by a belt-like arrangement of K/R residues. The
electrostatic potential was calculated from the non-linear Poisson–Boltzmann equation
using APBS software [105].
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DA uptake. In addition, cells expressing mutant hDAT constructs with
K3A/K5A or K3N/K5N substitutions were found to have impaired
AMPH-induced DA efﬂux but normal DA uptake. Remarkably, expres-
sion of hDAT K3A/K5A in Drosophila dopaminergic neurons did not
affect circadian locomotor activity yet diminished AMPH-induced
locomotion and neuronal DA efﬂux [62]. Collectively, these studies
support the role of direct electrostatic interactions between speciﬁc regions
of the DAT N-term and PIP2 lipids, and demonstrate that disruption of
DAT/PIP2 interactions selectively impairs reverse transport but not
substrate reuptake by DAT.
However, the key questions still remain whether PIP2 lipids directly
associatewith theN-terminal domains of otherNSS proteins, and if such
association relates to speciﬁc functional mechanisms. The studies in
SERT [63] have raised a possibility that the mutations identiﬁed in the
IC loops of this transporter have only indirect roles in the observed ef-
fects of PIP2. For example, since these loop regions are adjacent to the
N- and C-terminal segments, and likely interact with them in some
manner, it is reasonable to expect that loop residues can be involved
in mediating interactions between PIP2 and the terminal regions in
SERT, similar to observations in hDAT (see above). This is particularly
plausible in light of the suggested role of phosphorylation of the
N-term in SERT-mediated efﬂux process [87]. In this respect, it is inter-
esting to note that recent computational modeling of N- and C-terminal
regions of SERT in the context of the full-length transporter model [98]
has revealed the ﬂexible nature of these terminal domains and sug-
gested that the SERTN-term, in particular, can have large conformation-
al freedom when the transporter is in the inward-open state, which is
the conﬁguration that has been suggested to be important for efﬂux
[77].
More generally, the recent ﬁndings [62,63] discussed above, regard-
ing the role of N-term/PIP2 interactions, highlight the importance of
discerning the differentmolecularmechanisms that determine different
modes of NT function (i.e., efﬂux versus uptake), including the role of
phosphorylation at different sites in various segments of these terminal
regions.
4. Electrostatic interactions as key factors controlling structural and
functional mechanisms of the N-terminus in DAT
The experimental evidence presented above points to the role of the
many charged residues adjacent to Ser/Thr amino acids in the N-term
segment of NT proteins (Fig. 1) as key determinants of the mode of
interaction with PIP2 lipids and the modulation of the electrostatic prop-
erties by phosphorylation, and thus suggests that they are key elements
in the observed functional phenotypes. This hypothesiswas recently test-
ed at a detailed molecular level for the DAT N-term, as described below.
While the recently determined crystal structure of dDAThas provided
detailed information about the TM bundle of the transporter, the X-ray
model could not elucidate one of the key aspects of eukaryotic NSS
proteins that distinguish them from their bacterial counterparts,
i.e., the long IC N- and C-terminal domains. Indeed, the dDAT X-ray
model contains only a small part of the C-term, while the rest of it
(its more distal part) as well as the entire N-terminal region have
been excised from the experimental construct in order to enhance crys-
tallization. A structural prediction of the DAT N-term region was there-
fore undertaken [99] using the Rosetta ab initio structure prediction
algorithm [100]. The computational evaluation of three-dimensional
(3D) folds of the N-terminal fragments from the hDAT (residues
1–59) and VMAT2 (residues 1–20), described in full detail in Ref. [99],
was based on a computational protocol that included fold-prediction
of the N-termpeptideswith Rosetta and clustering the predicting struc-
tures (1000 per eachN-term construct) under various residue exclusion
criteria. Clusters containing a majority of the structures were identiﬁed
(top 2–3 clusters), and the selected models were the ones with the
lowest scores (from Rosetta energy function) in each cluster.Fig. 2 shows the predicted folds obtained in this manner for the
hDAT and VMAT2 N-term segments, as well as electrostatic potential
isosurfaces (EPI) calculated for these structures (see Fig. 2 captions for
the details of methodology). The N-term segments of the two NT-s are
characterized by well-deﬁned regions of strong positive EPI (blue
wireframe in Fig. 2) expressing the electrostatic effects of the multiple
basic residues that are positioned in speciﬁc 3D arrangements in these
constructs. The spatial properties of the EPI (note the positive EPI in
the hDAT N-term emerging from belt-like positioning of Lys/Arg resi-
dues) and their effect on interaction with PIP2 have been discussed
before [62]; the Lys/Arg residues in the 16-SRRSRK-20 stretch of the
N-term in VMAT2 are seen to generate a similarly strongly reinforced
positive EPI.
The structural models of the N-term were used in computational
studies to evaluate the mechanistic consequences of the well-deﬁned
reactivity features. The ability of the hDAT N-term to sequester PIP2
lipids was explored with several levels of computational modeling.
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were used to compare the conformational dynamics of the N-term
segment anchored to PIP2-enriched, and PIP2-depleted lipid mem-
branes. A single palmitoyl tail was attached to the C-terminal end of
the 65-residue long hDAT N-terminus to anchor the N-term at the
membrane surface (see Ref. [99] for more details).
Analysis of the accumulated trajectories revealed that the N-term
strongly associates with lipid membranes through interactions with
PIP2 lipids (compare panels A–B with D–E on Fig. 3) and identiﬁed
speciﬁc regions of the N-term in closest proximity to PIP2. These regions
include the distal N-term part harboring residues K3 and K5, and the far
end of the N-term, especially residues K27 and R51 (Fig. 3A–B). More-
over, the N-term/PIP2 mode of association involving the residue pair
K3/K5 was fully recapitulated in large-scale (N15 μs) MD simulations
carried out on the full length transporter model in an explicit all atom
membrane representation.Fig. 3. Illustration ofmodes of interaction of thehDATN-termwith PIP2 lipids in themembrane i
the chimera construct composed of the hDAT N-term and the dDAT TM bundle (C) (see Ref. [9
lationwith a PIP2-depletedmembrane. ThehDATN-terminus peptide (in pink) is next to the lipi
In all panels, lipid head group phosphate atoms are shown as orange spheres, the hDATN-term (
shown in space ﬁll and are labeled. Panels (A–C) also illustrate PIP2 lipidswithin 3 Å of the hDA
white cartoon.To evaluate the N-term/PIP2 interactions in an integrated model of
the transporter, the TM bundle of the recently determined dDAT struc-
ture was used to construct a chimera in which the terminal regions
were from the hDAT sequence, and a full-length hDAT model (Fig. 3C)
in which the TM bundle was obtained by homology modeling (see
Ref. [99] for more details). The simulations of the full-length hDAT
model identiﬁed a second site of interactions of the N-term with IC re-
gions of the transporter, which included the ICL4 segment. Extensive
simulations of this chimeric construct (Khelashvili et al, in preparation)
showed that thesemodes of interactions involve the R51 residue (in the
N-term) associating with the ICL4 region that contains the residue
equivalent to K460 in SERT, which has been implicated in efﬂux
mechanisms.
Interestingly, the computational approaches were able to quantify
the extent of PIP2 sequestration by the N-term of DAT. This was
achievedwith an established protocol [62,99,101–104], the quantitativen selected snapshots from long atomisticMD simulation (A–B), and from the simulations of
9] for more details). (D–E) Snapshots from various time-points in the atomistic MD simu-
dmembrane (orange spheres trace thepositions of the lipid head groupphosphate atoms).
residues 1–65) is depicted in pink cartoon, and residues K3, K5, K27, K19, K35, and R51 are
T N-term (rendered in licorice representation). In panel C the dDAT TM bundle is shown in
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Juxtamembrane poses of the N-terminus served as starting conﬁgura-
tions for following the dynamics of PIP2 lipids near the N-terminus
under the inﬂuence of electrostatic forces, taking into account self-
consistently the entropic contributions of mixing of lipids in the mem-
brane and moving ions in the surrounding solution (see Refs. [99,101,
102] for details about the SCMFM approach). The results illustrated in
Fig. 4 (top panel,WT) show that the conﬁguration of the N-term gener-
ating the largest EPI on the bilayer surface in which the K3/K5 pair is
facing the membrane produces a strong, ~2.5-fold increase in local
PIP2 levels (white shades in Fig. 4 color map) compared to ambient
(5%) PIP2 concentration (blue colors in Fig. 4). This level of segregation
of the PIP2 lipids out of the random distribution in the membrane, cor-
responds to the binding of two PIP2 lipid molecules near the K3/K5
pair and is consistent with the atomistic picture obtained from the MD
simulations (Fig. 3A–B). The calculations of PIP2 lipid aggregation
was carried out in [62] for the hDAT N-term mutants K3A/K5A and
K3N/K5N, because these mutations were found to yield an efﬂux-
incompetent transporter when incorporated into the full-length hDAT
construct [62]. Consonant with these ﬁndings, the mutant N-terms
were also foundnot to bind PIP2-containing liposomes and to exhibit di-
minished PIP2 segregation. The binding to PIP2-containing lipid mem-
branes was calculated to be unfavorable by ~3kBT [62] (where kB is
the Boltzmann constant, and T is the temperature).
4.1. Phospho-mimic mutations impair N-term/PIP2 interactions by altering
the electrostatic features of the hDAT N-term
As illustrated in Fig. 2, regions of positive EPI in the N-termmodels of
hDAT and VMAT2 contain Ser residues that have been shown to be
phosphorylated in the course of transporter activities. Computational
probing of the effect of phosphorylation of these Serines was carried
with constructs of the hDAT N-term obtained with the same RosettaFig. 4.View from the intracellular side, of hDATN-terminus (cartoon) adsorbing on the lipidme
the level of local PIP2 enrichment near the N-terminus is illustrated in color code representing
aggregation are shaded white (enrichment values N 1), whereas membrane areas depleted of P
are highlighted in space ﬁll and labeled on each panel. Steady state distribution of PIP2 around
the N-term 2 Å away from the lipid surface with average surface charge density of−0.0031e
equation was then solved numerically using APBS software [105] to obtain reduced electrostati
counterions (corresponding to λ= 9.65 Å Debye length), and using a dielectric constant of 2 fab initio protocol described above for the prediction of WT structures.
The mutant constructs were prepared with various single and multiple
phospho-mimic S/D mutations. Fig. 5 shows the speciﬁc constructs,
their predicted conformations and the EPI-s calculated for each of
them. Compared to the extended positive EPI in the wild type hDAT
N-term (Fig. 2B) the positive EPI is clearly diminished and disrupted
in all the S/D mutant peptides, as expected from the introduction of
additional negative charges into the hDAT N-term.
The consequences of the observed changes in electrostatic proper-
ties produced by the phospho-mimic mutations for the ability of the
N-term constructs to interact with PIP2 lipids, were evaluated with
calculations using the SCMFM approach described above. PIP2 lipid
aggregation around the S/D N-term variants (see Fig. 4) is seen to be
lower for the S/D mutants than for the wild type N-term (compare the
extent of white shades). Correspondingly, the adsorption free energies
(ΔG, Fig. 6) of the single S/D mutants are less favorable than for the
wild typeN-term. Among the single S/Dmutants considered,ΔGwas af-
fected strongest by the S2D and S7D variants, whereas overall the triple
mutation (S2D/S4D/S13D) showed the largest change (N3kBT) in
the adsorption free energy compared to the wild type construct. The
prediction based on these ﬁndings is that S/D mutations will reduce
N-term/PIP2 association.
4.2. A mechanistic model for the role of N-term/PIP2 association in the
function of neurotransmitter transporter proteins
Inferences from the experimental and modeling studies suggest
ways in which PIP2 lipids may be involved in the efﬂux phenotype.
One is that they may place the N-terminal segment next to the lipid
membrane in a position suitable for the required phosphorylation of
the distal serines (e.g., S7, S12) to be accomplished [62]. Another is
that they can regulate the involvement of various other segments of
the N-terminal domain in intra-protein interactions before, and after,mbrane. Panels showwild type (WT) and various S/Dmutants, as indicated. In each panel,
the ratio of local lipid fraction values to the value in the distal bulk regions. Regions of PIP2
IP2 are shown in dark blue colors (enrichment values b 1). The positively charged residues
a given peptide construct was calculated using the SCMFM approach [101,102], by placing
, which corresponds to a lipid mixture with ~5% PIP2. The non-linear Poisson–Boltzmann
c potential in space, as described previously [101], in a 0.1 M ionic solution of monovalent
or membrane interior and protein, and 80 for the solution.
Fig. 5. Electrostatic potential isosurfaces (EPIs) (+1kt/e shown as blue wireframes and−1kt/e as red wireframes) derived from the predicted structures for various S/D mutants of the
hDAT N-term, as indicated. Locations of basic residues are highlighted in yellow space-ﬁll representations, and are designated by corresponding labels and black arrows. The electrostatic
potential was calculated with the non-linear Poisson–Boltzmann equation using APBS software [105].
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vations in SERT [63] regarding interactions with the IC loop regions of
the transporter).Fig. 6. Steady-state adsorption free energies of hDAT N-term wild type, and phospho-
mimic constructs. Units are kBT.The results from computational studies on the hDAT N-term
discussed above indicate how PIP2 is involved in anchoring the
N-terminal domain to lipid membranes, and suggest that disruption of
electrostatic interactions between theN-term and themembrane either
by PIP2 depletion or charge neutralizing mutations in the distal K3/K5
residues result in N-term/membrane interactions that are energetically
less favorable compared to those under native conditions (i.e. wild type
N-term and PIP2-enriched membrane). It is reasonable to suspect that
when the N-term is no longer bound to the lipid membrane
(see Fig. 3), it could engage with the TM bundle of the transporter to
establish new interactions with different IC segments of the NT protein
that are usually enriched in positively charged residues. Notably, the
modes of interactionwith the TMbundle are likely to depend onwheth-
er the K3/K5 residues are neutralized and phosphorylation is impaired,
so that the modes of engagement with the TM domain may be quite
different from the ones established by the N-term when it carries addi-
tional negative charge(s) due to phosphorylation. Therefore, theN-term
phosphorylated in the distal region might support a conformation
favoring efﬂux, but the conformations explored by the N-term under
conditions of PIP2 depletion or charge-neutralizing mutations in K3/K5
positions, which will not support phosphorylation, can interfere with
the efﬂux phenotype. These alternatives establish speciﬁc mechanistic
hypotheses for the experimentally observed phenotypes that involve
the electrostatic interactions of speciﬁc residues and segments of the
N-term with PIP2 and/or the rest of the transporter. The discrete
1772 G. Khelashvili, H. Weinstein / Biochimica et Biophysica Acta 1848 (2015) 1765–1774molecular level of detail in which these hypotheses are expressed can
inform and guide the experimental elucidation of the efﬂux process
and shed important new light on the determinant involvement of the
membrane and its components.
5. Concluding remarks
The discovery that the strongly anionic PIP2 lipids known to reside in
the cytoplasmic leaﬂet of neuronal cell membranes, are essential for the
regulation of neurotransmitter transporter protein functions, under-
scores the mechanistic role of the cell membrane in cell signaling. As
illustrated previously [59], computational modeling is especially well
suited for the exploration of the many ways in which protein–
membrane interactions regulate structural and dynamic properties of
membrane proteins. Indeed, much progress has emerged from compu-
tational studies of the full-length hSERT [98] and hDAT [99] which
involved robust structure prediction algorithms combined with multi-
scalemodeling of protein/lipid interactions (ranging from extensive un-
biased atomisticMD simulations to continuummean-ﬁeld approaches).
The need for reliable 3D structural models of the transporter systems is
slowly being addressed by remarkable breakthroughs in crystallograph-
ic determinations of such structures [22,50] and carefully designed and
evaluatedmolecularmodels obtained from homologymodeling and re-
ﬁnements [2,10,41–46]. An essential complement in the explorations of
the interactions of such models with the membrane environment is
the identiﬁcation, from computational modeling, of reasonably stable
(during the course of long time-scale MD simulations [99]), and well-
structured elements in the N-terminal domain. This has been achieved
recently for DAT and other NT proteins (SERT [98], VMAT2). With this
progress, and taking advantage of thewealth of information about func-
tional andmechanistic properties gleaned from extensive studies of the
structurally known LeuT prototype [10,22,28–32,48], the studies char-
acterized by integrated experimental/computational approaches will
continue to guide the design of newways of exploring and understand-
ing transporter function and its multifaceted involvement in cell
signaling.
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